Dynamic change in ST-segment and spontaneous occurrence of ventricular fibrillation in Brugada syndrome with a novel nonsense mutation in the SCN5A gene during long-term follow-up

Circulation Journal

Volumn 73, Issue 3, 2009, Pages 584-588

  Kawamura, Mihoko ^a   Ozawa, Tomoya ^a   Yao, Takenori ^a   Ashihara, Takashi ^a   Sugimoto, Yoshihisa ^a   Yagi, Takafumi ^b   Itoh, Hideki ^a   Ito, Makoto ^a   Makiyama, Takeru ^c   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Second Okamoto General Hospital   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Brugada syndrome; Mutation; SCN5A; ST segment; Ventricular fibrillation

Indexed keywords

BEPRIDIL; SODIUM CHANNEL;

AGED; ARTICLE; BRUGADA SYNDROME; CASE REPORT; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FOLLOW UP; GENE; GENE LOCATION; GENETIC SCREENING; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE FIBRILLATION; HETEROZYGOSITY; HUMAN; LONG TERM CARE; MALE; NONSENSE MUTATION; PATCH CLAMP; R179X GENE; SCN5A GENE; ST SEGMENT; ST SEGMENT ELEVATION;

BRUGADA SYNDROME; CELLS, CULTURED; CODON, NONSENSE; ELECTROCARDIOGRAPHY; FAMILY HEALTH; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; PROTEIN STRUCTURE, TERTIARY; SODIUM CHANNELS; VENTRICULAR FIBRILLATION;

EID: 62649144085     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0142     Document Type: Article

References (27)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter report. J Am Coll Cardiol 1992; 20: 1391-1396.
2. + channel-blocker pilsicainide on the ST-segment response in the right precordial leads in patients with normal left ventricular function. Circ J 2007; 71: 57-62.
3. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST-segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061-1070.
4. Fujiki A, Usui M, Nagasawa H, Mizumaki K, Hayashi H, Inoue H. ST-segment elevation in the right precordial leads induced with class IC antiarrhythmic drug: Insight into the mechanism of Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10: 214-218.
5. Ohkubo K, Watanabe I, Takagi Y, Okumura Y, Ashino S, Kofune M, et al. Electrocadiographic and electrophysiologic characteristics in patients with Brugada type electrocardiogram and inducible ventricular fbrillation: Single center experience. Circ J 2007; 71: 1437-1441.
6. Chen Q, Kirsch G, Zhang D, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanism for idiopathic ventricular fbrillation. Nature 1998; 392: 293-296.
7. Tan HL, Bezzina CR, Smits JP, Verkerk AO, Wilde AA. Genetic control of sodium channel function. Cardiovasc Res 2003; 57: 961-973.
8. Makiyama T, Akao M, Tsuji K, Doi T, Ohno S, Takenaka K, et al. High risk for bradyarrhythmic complication in patients with Brugada syndrome caused by SCN5A gene mutations. J Am Coll Cardiol 2005; 46: 2100-2106.
9. Kalla H, Yan GX, Marinchak R. Ventricular fbrillation in a patient with prominent J (Osborn) waves and ST-segment elevation in the inferior electrocardiographic leads: A Brugada syndrome variant? J Cardiovasc Electrophysiol 2000; 11: 95-98.
10. Takagi M, Aihara N, Takaki H, Taguchi A, Shimizu W, Kurita T, et al. Clinical characteristics of patients with spontaneous or inducible ventricular fbrillation without apparent heart disease presenting with J wave and ST-segment elevation in inferior leads. J Cardiovasc Electrophysiol 2000; 11: 844-848.
11. Ogawa M, Kumagai K, Yamanouchi Y, Saku K. Spontaneous onset of ventricular fbrillation in Brugada syndrome with J wave and ST-segment elevation in the inferior lead. Heart Rhythm 2005; 2: 97-99.
12. Riera AR, Ferreira C, Schapachnik E, Sanches PC, Moffa PJ. Brugada syndrome with atypical ECG: Downsloping ST-segment elevation in inferior leads. J Electrocardiol 2004; 37: 101-104.
13. Sahara M, Sagara K, Yamashita T, Abe T, Kirigaya H, Nakada M, et al. J wave and ST-segment elevation in the inferior leads: A latent type of variant Brugada syndrome. Jpn Heart J 2002; 43: 55-60.
14. Ueyama T, Shimizu A, Esato M, Kanemoto M, Kametani R, Sawa A, et al. A case of a concealed type of Brugada syndrome with a J wave and mild ST-segment elevation in the inferolateral leads. Journal of Electrocardiology 2007; 40: 39-42.
15. Potet F, Mabo P, Le Coq G, Probst V, Schott JJ, Airaud F, et al. Novel Brugada SCN5A mutation leading to ST-segment elevation in the inferior or the right precordial leads. J Cardiovasc Electrophysiol 2003; 14: 200-203.
16. Wilde AA, Antzelevitch C, Borqqrefe M, Brugada J, Brugada R, Brugada P, et al. Proposed diagnostic criteria for the Brugada syndrome: Consensus report. Circulation 2002; 106: 2514-2519.
17. Antzelevitch C, Brugada P, Borqqrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: Report of the second consensus conference. Heart Rhythm 2005; 4: 429-440.
18. Wang Q, Li Z, Shen J, Keating MT. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996; 34: 9-19.
19. Shirai N, Makita N, Sasaki K, Yokoi H, Sakuma I, Sakurada H, et al. A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease. Cardiovasc Res 2002; 53: 348-354.
20. Ohno S, Zankov DP, Yoshida H, Tsuji K, Makiyama T, Itoh H, et al. N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome. Heart Rhythm 2007; 4: 332-340.
21. + channels. J Neurosci 1996; 16: 7117-7127.
22. Akai J, Makita N, Sakurada H, Shirai N, Ueda K, Kitabatake A, et al. A novel SCN5A mutation associated with idiopathic ventricular fbrillation without typical ECG fndings of Brugada syndrome. FEBS Lett 2000; 479: 29-34.
23. Antzelevitch C. The Brugada syndrome: Ionic basis and arrhythmia mechanism. J Cardiovasc Electrophysiol 2001; 12: 268-272.
24. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999; 100: 1660-1666.
25. Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, et al. Idiopathic ventricular fbrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997; 95: 2277-2285.
26. Litovsky SH, Antzelevitch C. Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol: A direct effect of acetylcholine in ventricular myocardium. Circ Res 1990; 67: 615-627.
27. Gong Q, Zhang L, Vincent M, Horne BD, Zhou Z. Nonsense mutation in hERG causes a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay (NMD) in human long-QT syndrome. Circulation 2007; 116: 17-24.